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Antiepileptic drug withdrawal in dogs
with epilepsy
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Epilepsy is one of the most common neurological disorders in dogs and is treated by
chronic administration of antiepileptic drugs (AEDs). In human beings with epilepsy, it is
common clinical practice to consider drug withdrawal after a patient has been in remission
(seizure free) for three or more years, but withdrawal is associated with the risk of relapse.
In the present study, the consequences of AED withdrawal were studied in dogs with
epilepsy. Therefore, 200 owners of dogs with idiopathic or presumed idiopathic epilepsy
were contacted by telephone interview, 138 cases could be enrolled. In 11 cases, the
therapy had been stopped after the dogs had become seizure free for a median time
of 1 year. Reasons for AED withdrawal were appearance or fear of adverse side effects,
financial aspects, and the idea that the medication could be unnecessary. Following AED
withdrawal, four of these dogs remained seizure free, seven dogs suffered from seizure
recurrence, of which only three dogs could regain seizure freedom after resuming AED
therapy. Due to the restricted case number, an exact percentage of dogs with seizure
recurrence after AED withdrawal cannot be given. However, the present study gives a
hint that similar numbers as in human patients are found, and the data can help owners of
epileptic dogs and the responsible clinician to decide when and why to stop antiepileptic
medication.
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Introduction
Epilepsy is one of themost commonneurological disorders in dogs (1), characterized by spontaneous
recurrent seizures originating in the central nervous system (2). The prevalence of canine epilepsy
varies in different studies between 0.5% and 5% (1). If no underlying cause except of hereditary
factors are found for the recurrent seizures in the diagnostic work-up, epilepsy is classified as
idiopathic (3). Most canine patients that suffer from idiopathic epilepsy experience their first seizure
event at an age of 1–5 years (4).
As in human beings, dogs with epilepsy are typically treated with antiepileptic drugs (AEDs) and
about 40% become seizure free (1). Epilepsy can also remit spontaneously (5). The risk of recurrence
of seizures after AED withdrawal in dogs that became seizure free during treatment is not known.
There are different reasons to discontinue treatment with AEDs in dogs, including medical causes
or owners’ perception. Some owners may not accept long-term or lifelong epilepsy treatment and
as a consequence may even consider euthanasia as an alternative to treatment (1). Financial aspects
could be another reason to withdraw AEDs after a seizure-free period. A better knowledge of the
possible outcome in such cases could help owners and responsible clinicians to calculate the potential
risk of recurring seizures and to find the right decision concerning treatment discontinuation.
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In human patients, behavioral and cognitive side effects are well-
known adverse events in patients treated with AEDs and are
shown to improve after drug tapering (6, 7). Other aspects for the
decision of treatment discontinuation in human beings include
the risk of teratogenicity, drug interactions with concurrent med-
ications, and the concern that treatment might be unnecessary
(8). The last reason might reflect owners perception in veterinary
medicine. Withdrawal of AEDs in dogs may be attempted after a
seizure-free period for >1 year but the risk of seizure recurrence
has to be considered (1).
In human studies, the probability of relapse after planned
discontinuation of treatment has varied between 12% and 66%
in different studies (9). The chance of AED withdrawal with-
out relapse was greater in patients with a seizure-free period on
therapy of 2–5 years, a single reported seizure type, a normal
neurological exam, and a normalized EEG under treatment (10).
But apart from clinical experience, no clear guidelines are given
in order to answer the question of the right timing and safety of
AED withdrawal (11) and insufficient evidence exists to guide the
timing of withdrawal of AEDs in seizure-free adults. In children,
there is evidence to support waiting for at least two seizure-free
years before discontinuing AEDs (12).
The hypothesis of this study was that only a part of canine
patients will remain seizure free after AEDwithdrawal. Therefore,
the outcome of a group of dogs with idiopathic or presumed
idiopathic epilepsy that had discontinued antiepileptic treatment
was investigated.
Materials and Methods
The study was designed as a retrospective study using data of
patients with epilepsy examined at the Department of Small
Animal Medicine and Surgery of the University of Veterinary
Medicine Hannover. The study was performed according to the
ethical rules of the University. A thesis committee approved the
study; the owners gave their written consent to use the data for
a scientific study. Before the telephone interview, the owners
were informed about the purpose of the study. The diagnosis
or presumed diagnosis of idiopathic epilepsy was made based
on typical history (4) and normal routine clinical and neuro-
logical examination. No abnormalities on hemogram or blood
chemistry profile were detected. If magnetic resonance imaging
(MRI) and cerebrospinal fluid (CSF) evaluation were performed,
no abnormalities were detected (Table 1).
The owners of dogs with idiopathic or presumed idiopathic
epilepsy were contacted by telephone calls. Follow-up informa-
tion was gathered by the use of a questionnaire, including age
at first seizure event, the predominant seizure type, occurrence
of cluster seizures, treatment, and eventual AED withdrawal.
In cases with discontinuation of treatment with AEDs, it was
noted whether seizures recurred and differed from the previous
seizure types. Furthermore, questions were included to note, if
these recurrent seizures could be controlled again with a new
treatment attempt (see telephone questionnaire in Supplementary
Material).
A total of 200 cases with idiopathic or presumed idiopathic
epilepsy were collected for the telephone interview. In 62 of these TA
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200 cases, either the owners could not be reached because of
missing contact details or no information about the dog was
available. In 11 of the 138 evaluated patients, the AEDs were with-
drawn after the dogs became seizure free for a certain time period
(Table 1).
Results
In 11 (8%) of the 138 cases with successfully completed telephone
interviews, the AEDs, inmost cases phenobarbital, had beenwith-
drawn (Table 1). The withdrawal was conducted in a controlled
way after step by step reduction of the AED dosage over a required
time period, but varied widely between about 1 and 3months
according to the recommendation of the private practitioner. Of
these patients, 10 dogs were male (nine intact, one neutered) and
one dog was female.
Except one dog that received phenobarbital and zonisamide,
all patients with AED withdrawal had received only one AED.
Eight of these patients were treated with phenobarbital prior to
withdrawal, one dog with potassium bromide, and one dog with
imepitoin (13). Serum drug concentrations were not available in
all dogs at the timepoint of drug withdrawal.
Eight dogs (72.7%) of these patients had received the drugs
for at least a minimum of 1 year prior to drug withdrawal. One
dog had received treatment for only 3months and another for
9months. In one case, the owner only estimated the time period
under treatment with several months. The maximum of the time
period under treatment had been 5 years prior to drugwithdrawal.
Median time of treatment prior to withdrawal was 1 year. The
medication of each dog is shown in Table 1.
The reasons for the owners to withdraw the AEDs had been
appearance or fear of adverse side effects (two dogs), financial
burden (one dog), and/or the feeling or the desire that AEDs could
be unnecessary (eight dogs).
Four (36.4%) of the 11 dogs with withdrawal of antiepilep-
tic treatment after a seizure-free period remained seizure free.
The follow-up period after the withdrawal of the AED for these
dogs was between 2 and 7 years (2, 6, 6.5, and 7 years). Seven
dogs (63.6%) showed recurrence of seizures after withdrawal.
Their primary seizure type before AED withdrawal, loss of con-
sciousness during the seizure, or appearance of cluster seizures is
shown in Table 1. Of these patients, three dogs (42.8%) became
seizure free again after restarting antiepileptic treatment. The
follow-up period after the new therapy attempt was between
0.5 and 5 years. In two dogs (25.6%), seizures could not be
controlled again. One of these patients had to be euthanized
because of recurrent seizures resistant to a new therapy attempt
on the request of the owner. The other one was treated with
the same medication (phenobarbital) as given before AED with-
drawal and with potassium bromide as an add-on treatment.
The follow-up period for this dog after recurrence of seizures
was 5 years. In this patient, the seizure type was equal to the
seizures before withdrawal and seizure frequency was low (one
seizure/3months). In two cases (25.6%), the owners did not try a
new antiepileptic treatment because the frequency of the recurrent
seizures was much lower and the owners were satisfied with this
outcome.
Discussion
In most cases, the therapy of an epileptic dog involves a long-
term or even lifelong treatment with AEDs (2, 3). However,
the duration of antiepileptic treatment is sometimes decided in
an individual way for each patient. The decision of discontin-
uing AEDs is a question facing both the owner of an epileptic
dog and the responsible clinician. In human medicine, there are
some known factors that increase the risk of seizure recurrence
after AED withdrawal. Risk factors for seizure recurrence are an
adolescent-onset epilepsy, a longer duration of epilepsy, occur-
rence of partial seizures, an abnormal neurological examination,
and an abnormal EEG (8–10). In veterinary medicine, the owners
may ask for withdrawal of AEDs for different reasons. In our
study, these reasons were the appearance or fear of adverse side
effects, the financial burden, and/or the feeling that AEDs could
be unnecessary. But as in human beings, the withdrawal of AEDs
in the canine patient is a well-known risk and even after a seizure-
free period the patient might develop recurrent seizures after
drug withdrawal as shown in the current study. Furthermore, the
seizures may appear more frequently and less controllable after
tapering AEDs. In a review of the clinical literature, Schmidt
and Löscher (9) found that between 12% and 66% of seizure-
free human patients relapsed after planned discontinuation of
AEDs. Reinstitution of AEDs after recurrence was efficacious in
only 80% (range 64%–91%) of the patients (9). Factors associated
with poor treatment outcome of treating recurrences were symp-
tomatic etiology, partial epilepsy, and cognitive deficits. In the
canine patients, similar studies are not available to the best of the
author’s knowledge, and no other guidelines than personal clinical
experience of the veterinarian are considered for prognosis and
outcome estimation.
In the current study, in 11 of 138 dogs with idiopathic or
presumed idiopathic epilepsy AEDs had been withdrawn. Albeit
a large number of dogs with long-term antiepileptic treatment
were evaluated, medication was stopped only in a small part of
these dogs. As already reported in the literature for humanpatients
(9), some of these dogs suffered from seizure recurrences, others
remained seizure free. The distributionwas 36.4% dogs remaining
seizure free and 63.6%with recurrence of seizures reflecting a high
rate of seizure recurrence. On the other hand, this result supports
the common opinion that withdrawal of antiepileptic treatment
after a seizure-free period might be successful in at least a part
of the patients. But as shown by our study, it is very important
to control the patients in the time of withdrawal because seizure
recurrence is a risk that should not be underestimated.
Recurring seizures after AED withdrawal can be divided into
recurrence of the original epilepsy, a drug withdrawal (“rebound”)
phenomenon or drug resistance that evolved during the drug
discontinuation (9). In our cases, it is not possible to determine
exactly the underlying type because in the most cases the new
therapy attempt started immediately after the recurrence of new
seizure events. In those cases where the owners did not want to
try a new therapy attempt, it was probably not just a drug with-
drawal phenomenon associated with physical dependence during
treatment (see below) because the seizures remained present in
these dogs for the rest of their lives.
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In three of the seven patients with seizure recurrence, seizures
were already observed during the time of withdrawal. In another
patient, the seizures occurred 1month after withdrawal. There-
fore, the time interval for a higher risk of seizure recurrence seems
to be during the withdrawal time itself and in the immediate time
afterward. Most epileptic dogs are treated with phenobarbital,
which is one of the few AEDs approved for treatment of epilepsy
in dogs, but leads to development of physical dependence and the
risk of withdrawal seizures upon termination of treatment (14).
Dogs should be carefully controlled and observed when the owner
decides to withdraw the AEDs in order to recognize and treat
potential seizures.
The decision to withdraw AEDs might also be affected by the
risk of occurrence of refractory seizures. In human being, the
reinstitution of AEDs after recurrent seizures after drug with-
drawal resulted in seizure remission in 64%–91% (8). In our study,
the owners of two patients did not want to try a new treatment
attempt. Three of the other five patients were seizure free again
after restarting AEDs. Of the remaining two cases, one dog was
euthanized due to uncontrolled recurrent seizures. The other one
responded to the treatment, but was not seizure free anymore.
Therefore, the owners have to be aware that eventually recurrent
seizures following AED withdrawal may be less controllable to
AEDs.
In the current study, 11/138 cases with AED withdrawal were
investigated. Most of the contacted owners did not discontinue
the medication and seemed to be satisfied with the result of
achieving seizure freedom or reduced seizure frequency with
a lifelong therapy. Despite the limited number of patients, our
study shows that different outcomes after drug withdrawal are
to be expected. Besides a good prognosis or outcome, seizure
recurrence was observed in the withdrawal period itself and the
immediate months afterward. A good compliance is absolutely
necessary when trying to discontinue AEDs in dogs with epilepsy.
Owners should control their dogs very carefully in this time
period in order to recognize signs of seizure recurrence as fast as
possible.
Supplementary Material
The Supplementary Material for this article can be found online
at http://journal.frontiersin.org/article/10.3389/fvets.2015.00023
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